Chief of Neurology, Mass General, Director of the Sean M. Healey & AMG Center for ALS at Mass General, Julieanne Dorn Professor of Neurology, Harvard Medical School, Director of the Mass General Neurological Clinical Research Institute, Co-Founder and past Co-Chair of the Northeast ALS Consortium
Maurizio Fava, MD, psychiatrist-in-chief and director of the Division of Clinical Research in the Mass General Research Institute. In 2007, he founded and is now Executive Director of the Mass General Psychiatry Clinical Trials Network and Institute (CTNI), the first academic CRO specialized in planning and coordination of multi-center clinical trials in psychiatry.
William T. Curry, MD, is the co-director of Mass General Neuroscience and director of Neurosurgical Oncology in the Department of Neurosurgery. He provides surgical care for patients with benign and malignant tumors of the brain, skull-base, and spine. Dr. Curry leads and participates in multiple clinical trials for patients with brain tumors and is particularly interested in the development of cellular and immune-based therapies for malignant tumors.
Dr. Ramesh is a Professor of Neurology at Harvard Medical School and an Associate Neurologist at MGH. Her laboratory works on NF2 and TSC, employing disease-relevant human cellular models to discover pathways and mechanisms of pathophysiology and using the results to identify single and combination drug treatment, which could be translated into the clinic.
Dr. Ana-Maria Vranceanu is a clinical health psychologist, Associate Professor of Psychology at Harvard Medical School, and Founding Director of the Integrated Brain Health Clinical and Research Program (IBHCRP). She is an expert in behavioral intervention development and testing as well as in-person and live video mind-body and lifestyle modification programs.
Support Mass General Neurotherapeutics
Massachusetts General Hospital Neuroscience clinical trials seeks to prevent and treat brain based diseases while advancing the development of novel therapies.